Sign up to save your podcasts
Or
Share E44: SELECT-COMPARE Upadacitinib (JAKi) for Rheumatoid Arthritis
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
E44: SELECT-COMPARE Upadacitinib (JAKi) for Rheumatoid Arthritis
Finally got around to tackling the JAKi this week. I decided to focus on SELECT-COMPARE, which pitted upadacitinib (selective JAK1 inhibitor) against adalimumab and placebo. I briefly discuss other JAKs and my thoughts on the future of this area. Get the paper and others at ebrheum.com and follow me @ebrheum!
View all episodes
By Michael Putman
4.9
111111 ratings
Finally got around to tackling the JAKi this week. I decided to focus on SELECT-COMPARE, which pitted upadacitinib (selective JAK1 inhibitor) against adalimumab and placebo. I briefly discuss other JAKs and my thoughts on the future of this area. Get the paper and others at ebrheum.com and follow me @ebrheum!
More shows like The Evidence Based Rheumatology Podcast
View all
JAMA Clinical Reviews
494 Listeners
Rheumnow Podcast
117 Listeners
The Curbsiders Internal Medicine Podcast
3,320 Listeners
Core IM | Internal Medicine Podcast
1,081 Listeners
Healio Rheuminations
119 Listeners
The Clinical Problem Solvers
514 Listeners
ACR on Air
67 Listeners
Around the Rheum
5 Listeners
Rheumatology For The Royal College
170 Listeners
RheumMadness Podcast
11 Listeners
The Lancet Rheumatology in conversation with
0 Listeners
Talking Rheumatology Research
1 Listeners
Talking Rheumatology
0 Listeners
Talking Rheumatology Spotlight
5 Listeners
ACR Journals On Air
18 Listeners